Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1682818

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1682818

NIPT Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

PUBLISHED:
PAGES: 230 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The non-invasive prenatal testing (NIPT) market is experiencing significant growth, driven by the increasing prevalence of chromosomal abnormalities and the rising demand for early detection methods. In 2024, the market size is estimated at USD 7.1 billion and is projected to reach USD 21.2 billion by 2032, advancing at a compound annual growth rate (CAGR) of 14.7% during the forecast period.

This growth is primarily attributed to the increasing prevalence of chromosomal abnormalities and rising demand for early detection methods. Approximately 14% of stillbirths are due to inherited diseases in pregnant women under 24 years old, with the number rising to 38% in women aged 40-44.

Key Insights

NIPT is predominantly used for detecting trisomies, with Trisomy 21 (Down syndrome) being the most common chromosomal abnormality. In the U.S., more than 5,000 babies are born with Down syndrome annually, equating to an incidence of 1 in 800 newborns. The likelihood of Down syndrome increases with maternal age, and infants born with this condition often have low birth weights, with approximately 85% dying within a year and only 50% living longer than 50 years.

The adoption of advanced technologies, such as next-generation sequencing (NGS), has enhanced the accuracy and efficiency of NIPT. NGS facilitates the detection of chromosomal abnormalities by analyzing fetal DNA present in maternal blood, leading to early and reliable diagnoses.

Diagnostic laboratories are the primary end-users of NIPT, owing to their specialized equipment and expertise in genetic testing. Hospitals and research institutes also utilize NIPT, reflecting its integration into prenatal care and ongoing genetic research.

North America holds the largest market share, attributed to the high adoption rate of advanced diagnostic technologies and well-established healthcare infrastructure. The Asia-Pacific region is anticipated to witness the fastest growth, driven by increasing healthcare awareness, rising disposable incomes, and expanding access to prenatal care services.

The NIPT market is fragmented, with numerous players offering a variety of products to cater to diverse consumer needs. Major companies in the market include Illumina Inc., Eurofins Scientific SE, Myriad Women's Health Inc., PerkinElmer Inc., Agilent Technologies Inc., QIAGEN N.V., Danaher Corporation, Bio-Rad Laboratories Inc., Laboratory Corp. of America Holdings, Quest Diagnostics Inc., Yourgene Health plc, and Thermo Fisher Scientific Inc.

Product Code: 10347

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by method
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by end user
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2019-2030)
    • 6.2.1. Consumables market revenue, by type (2019-2030)
    • 6.2.2. Instruments market revenue, by type (2019-2030)
  • 6.3. Market Revenue, by Method (2019-2030)
  • 6.4. Market Revenue, by Application (2019-2030)
  • 6.5. Market Revenue, by End User (2019-2030)
  • 6.6. Market Revenue, by Region (2019-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2019-2030)
    • 7.2.1. Consumables market revenue, by type (2019-2030)
    • 7.2.2. Instruments market revenue, by type (2019-2030)
  • 7.3. Market Revenue, by Method (2019-2030)
  • 7.4. Market Revenue, by Application (2019-2030)
  • 7.5. Market Revenue, by End User (2019-2030)
  • 7.6. Market Revenue, by Country (2019-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2019-2030)
    • 8.2.1. Consumables market revenue, by type (2019-2030)
    • 8.2.2. Instruments market revenue, by type (2019-2030)
  • 8.3. Market Revenue, by Method (2019-2030)
  • 8.4. Market Revenue, by Application (2019-2030)
  • 8.5. Market Revenue, by End User (2019-2030)
  • 8.6. Market Revenue, by Country (2019-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2019-2030)
    • 9.2.1. Consumables market revenue, by type (2019-2030)
    • 9.2.2. Instruments market revenue, by type (2019-2030)
  • 9.3. Market Revenue, by Method (2019-2030)
  • 9.4. Market Revenue, by Application (2019-2030)
  • 9.5. Market Revenue, by End User (2019-2030)
  • 9.6. Market Revenue, by Country (2019-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2019-2030)
    • 10.2.1. Consumables market revenue, by type (2019-2030)
    • 10.2.2. Instruments market revenue, by type (2019-2030)
  • 10.3. Market Revenue, by Method (2019-2030)
  • 10.4. Market Revenue, by Application (2019-2030)
  • 10.5. Market Revenue, by End User (2019-2030)
  • 10.6. Market Revenue, by Country (2019-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2019-2030)
    • 11.2.1. Consumables market revenue, by type (2019-2030)
    • 11.2.2. Instruments market revenue, by type (2019-2030)
  • 11.3. Market Revenue, by Method (2019-2030)
  • 11.4. Market Revenue, by Application (2019-2030)
  • 11.5. Market Revenue, by End User (2019-2030)
  • 11.6. Market Revenue, by Country (2019-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2019-2030)
    • 12.2.1. Consumables market revenue, by type (2019-2030)
    • 12.2.2. Instruments market revenue, by type (2019-2030)
  • 12.3. Market Revenue, by Method (2019-2030)
  • 12.4. Market Revenue, by Application (2019-2030)
  • 12.5. Market Revenue, by End User (2019-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2019-2030)
    • 13.2.1. Consumables market revenue, by type (2019-2030)
    • 13.2.2. Instruments market revenue, by type (2019-2030)
  • 13.3. Market Revenue, by Method (2019-2030)
  • 13.4. Market Revenue, by Application (2019-2030)
  • 13.5. Market Revenue, by End User (2019-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2019-2030)
    • 14.2.1. Consumables market revenue, by type (2019-2030)
    • 14.2.2. Instruments market revenue, by type (2019-2030)
  • 14.3. Market Revenue, by Method (2019-2030)
  • 14.4. Market Revenue, by Application (2019-2030)
  • 14.5. Market Revenue, by End User (2019-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2019-2030)
    • 15.2.1. Consumables market revenue, by type (2019-2030)
    • 15.2.2. Instruments market revenue, by type (2019-2030)
  • 15.3. Market Revenue, by Method (2019-2030)
  • 15.4. Market Revenue, by Application (2019-2030)
  • 15.5. Market Revenue, by End User (2019-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2019-2030)
    • 16.2.1. Consumables market revenue, by type (2019-2030)
    • 16.2.2. Instruments market revenue, by type (2019-2030)
  • 16.3. Market Revenue, by Method (2019-2030)
  • 16.4. Market Revenue, by Application (2019-2030)
  • 16.5. Market Revenue, by End User (2019-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2019-2030)
    • 17.2.1. Consumables market revenue, by type (2019-2030)
    • 17.2.2. Instruments market revenue, by type (2019-2030)
  • 17.3. Market Revenue, by Method (2019-2030)
  • 17.4. Market Revenue, by Application (2019-2030)
  • 17.5. Market Revenue, by End User (2019-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2019-2030)
    • 18.2.1. Consumables market revenue, by type (2019-2030)
    • 18.2.2. Instruments market revenue, by type (2019-2030)
  • 18.3. Market Revenue, by Method (2019-2030)
  • 18.4. Market Revenue, by Application (2019-2030)
  • 18.5. Market Revenue, by End User (2019-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2019-2030)
    • 19.2.1. Consumables market revenue, by type (2019-2030)
    • 19.2.2. Instruments market revenue, by type (2019-2030)
  • 19.3. Market Revenue, by Method (2019-2030)
  • 19.4. Market Revenue, by Application (2019-2030)
  • 19.5. Market Revenue, by End User (2019-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2019-2030)
    • 20.2.1. Consumables market revenue, by type (2019-2030)
    • 20.2.2. Instruments market revenue, by type (2019-2030)
  • 20.3. Market Revenue, by Method (2019-2030)
  • 20.4. Market Revenue, by Application (2019-2030)
  • 20.5. Market Revenue, by End User (2019-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2019-2030)
    • 21.2.1. Consumables market revenue, by type (2019-2030)
    • 21.2.2. Instruments market revenue, by type (2019-2030)
  • 21.3. Market Revenue, by Method (2019-2030)
  • 21.4. Market Revenue, by Application (2019-2030)
  • 21.5. Market Revenue, by End User (2019-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2019-2030)
    • 22.2.1. Consumables market revenue, by type (2019-2030)
    • 22.2.2. Instruments market revenue, by type (2019-2030)
  • 22.3. Market Revenue, by Method (2019-2030)
  • 22.4. Market Revenue, by Application (2019-2030)
  • 22.5. Market Revenue, by End User (2019-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2019-2030)
    • 23.2.1. Consumables market revenue, by type (2019-2030)
    • 23.2.2. Instruments market revenue, by type (2019-2030)
  • 23.3. Market Revenue, by Method (2019-2030)
  • 23.4. Market Revenue, by Application (2019-2030)
  • 23.5. Market Revenue, by End User (2019-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2019-2030)
    • 24.2.1. Consumables market revenue, by type (2019-2030)
    • 24.2.2. Instruments market revenue, by type (2019-2030)
  • 24.3. Market Revenue, by Method (2019-2030)
  • 24.4. Market Revenue, by Application (2019-2030)
  • 24.5. Market Revenue, by End User (2019-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2019-2030)
    • 25.2.1. Consumables market revenue, by type (2019-2030)
    • 25.2.2. Instruments market revenue, by type (2019-2030)
  • 25.3. Market Revenue, by Method (2019-2030)
  • 25.4. Market Revenue, by Application (2019-2030)
  • 25.5. Market Revenue, by End User (2019-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2019-2030)
    • 26.2.1. Consumables market revenue, by type (2019-2030)
    • 26.2.2. Instruments market revenue, by type (2019-2030)
  • 26.3. Market Revenue, by Method (2019-2030)
  • 26.4. Market Revenue, by Application (2019-2030)
  • 26.5. Market Revenue, by End User (2019-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2019-2030)
    • 27.2.1. Consumables market revenue, by type (2019-2030)
    • 27.2.2. Instruments market revenue, by type (2019-2030)
  • 27.3. Market Revenue, by Method (2019-2030)
  • 27.4. Market Revenue, by Application (2019-2030)
  • 27.5. Market Revenue, by End User (2019-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2019-2030)
    • 28.2.1. Consumables market revenue, by type (2019-2030)
    • 28.2.2. Instruments market revenue, by type (2019-2030)
  • 28.3. Market Revenue, by Method (2019-2030)
  • 28.4. Market Revenue, by Application (2019-2030)
  • 28.5. Market Revenue, by End User (2019-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Seqenom Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Aerosa Diagnostics Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Natera Inc.
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Illumina Inc.
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Eurofins Scientific
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. MedGemone Labs Ltd.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Yourgene Health Plc
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. F Hoffmann La-Roche Ltd.
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Genesis Genetics
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Centogene GmBH
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!